News
Clinical Trials Arena on MSN13h
ANI Pharmaceuticals reports outcomes from diabetic macular oedema trial
ANI Pharmaceuticals has disclosed the outcomes of its NEW DAY trial, assessing Iluvien 0.19mg, in people with diabetic macular oedema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback